Cordyceps vs Rhodiola Rosea
Two adaptogenic supplements sold for energy and stress resilience — one with modest aerobic gains only in untrained people, the other with a real but short-term stress-fatigue signal.
Short answer
Both are supplements with some human trials behind them, so what separates cordyceps and Rhodiola rosea is the goal. For a reader focused on energy, endurance and VO₂max, cordyceps is the relevant choice; Rhodiola rosea is marketed for stress, fatigue and focus.
Cordyceps
Small trials show modest aerobic gains in older or untrained people but nothing in trained athletes; the cordycepin mechanism is mostly preclinical.
Full Cordyceps evidence reviewRhodiola Rosea
Several placebo-controlled RCTs show a short-term benefit for stress-related fatigue and mental performance — but trials are small/lower-quality and systematic reviews call it promising, not proven.
Full Rhodiola Rosea evidence reviewCordyceps vs Rhodiola Rosea: head to head
- FDA status / approved use
Cordyceps
Sold as a supplement, nearly always fermented Cs-4 or cultivated C. militaris, not wild fungusRhodiola Rosea
Herbal adaptogen supplement; not a treatment for clinical depression or any diagnosed condition- Marketed for
Cordyceps
Energy, endurance, VO₂maxRhodiola Rosea
Stress, fatigue, focus- Outcome areas
Cordyceps
Exercise performance / endurance; Mitochondrial / cellular energyRhodiola Rosea
Mood / anxiety / stress; Cognitive function / memory; Mitochondrial / cellular energy- Evidence grade
Cordyceps
Clinical dataRhodiola Rosea
Clinical data- How it works
Cordyceps
Cordycepin, an adenosine analog, may support cellular energy; evidence mostly preclinicalRhodiola Rosea
Adaptogen claimed to help the body resist stress; active markers rosavins and salidroside- Route and dosing
Cordyceps
Oral supplement; 333 mg three times daily in a 12-week trialRhodiola Rosea
Oral standardized extract, commonly 200 to 400 mg/day- Headline human result
Cordyceps
Metabolic threshold up 10.5 percent, VO2max unchanged, in a 12-week Cs-4 trial of 20 older adults; no benefit in trained cyclistsRhodiola Rosea
Greater fatigue reduction than placebo after 28 days of standardized SHR-5 extract in an RCT of adults with stress-related fatigue- Strongest evidence
Cordyceps
Chen, J Altern Complement Med 2010Cordyceps evidence reviewPubMed 20804368Rhodiola Rosea
Olsson RCT, Planta Med 2009Rhodiola Rosea evidence reviewPubMed 19016404- Key safety signal
Cordyceps
Generally well tolerated in studies, with mostly mild effectsRhodiola Rosea
Mild dizziness, dry mouth or jitteriness; may interact with antidepressants, stimulants, blood-pressure or blood-sugar drugs- How it is obtained
Cordyceps
Over the counter as a dietary supplementRhodiola Rosea
Over the counter as a dietary supplement
| Cordyceps | Rhodiola Rosea | |
|---|---|---|
| FDA status / approved use | Sold as a supplement, nearly always fermented Cs-4 or cultivated C. militaris, not wild fungus | Herbal adaptogen supplement; not a treatment for clinical depression or any diagnosed condition |
| Marketed for | Energy, endurance, VO₂max | Stress, fatigue, focus |
| Outcome areas | Exercise performance / endurance; Mitochondrial / cellular energy | Mood / anxiety / stress; Cognitive function / memory; Mitochondrial / cellular energy |
| Evidence grade | Clinical data | Clinical data |
| How it works | Cordycepin, an adenosine analog, may support cellular energy; evidence mostly preclinical | Adaptogen claimed to help the body resist stress; active markers rosavins and salidroside |
| Route and dosing | Oral supplement; 333 mg three times daily in a 12-week trial | Oral standardized extract, commonly 200 to 400 mg/day |
| Headline human result | Metabolic threshold up 10.5 percent, VO2max unchanged, in a 12-week Cs-4 trial of 20 older adults; no benefit in trained cyclists | Greater fatigue reduction than placebo after 28 days of standardized SHR-5 extract in an RCT of adults with stress-related fatigue |
| Strongest evidence | Chen, J Altern Complement Med 2010Cordyceps evidence reviewPubMed 20804368 | Olsson RCT, Planta Med 2009Rhodiola Rosea evidence reviewPubMed 19016404 |
| Key safety signal | Generally well tolerated in studies, with mostly mild effects | Mild dizziness, dry mouth or jitteriness; may interact with antidepressants, stimulants, blood-pressure or blood-sugar drugs |
| How it is obtained | Over the counter as a dietary supplement | Over the counter as a dietary supplement |
marks a row where the two differ. “Not established” marks a cell the available evidence does not answer. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
- Clinical data:
- Tested in humans — but investigational, discontinued, or proven only on a surrogate marker (not the marketed outcome).
Our verdict
Cordyceps shows small aerobic-capacity gains in older or untrained users, but nothing in already-fit athletes, and its cordycepin mechanism is still mostly preclinical. Rhodiola's evidence is a genuine, if lower-quality, body of placebo-controlled trials for short-term stress-related fatigue and mental performance — systematic reviews call it promising rather than proven. Neither has a trial supporting the general 'adaptogen' framing both are marketed under.
Cordyceps fits if
You're untrained or older and specifically want the aerobic-capacity angle — it won't do much if you're already fit.
Rhodiola Rosea fits if
Acute stress-related fatigue or mental performance under pressure is the target, understanding the trial quality is modest.
Cordyceps vs Rhodiola Rosea: common questions
- Is either cordyceps or Rhodiola rosea FDA-approved?
- No. Cordyceps is sold as a supplement, nearly always fermented Cs-4 or cultivated C. militaris, not wild fungus. Rhodiola rosea is an herbal adaptogen supplement; not a treatment for clinical depression or any diagnosed condition.
- Which has stronger human evidence, cordyceps or Rhodiola rosea?
- Neither clearly. Both have human clinical data. The key source for cordyceps is Chen, J Altern Complement Med 2010; for Rhodiola rosea, it is Olsson RCT, Planta Med 2009.
- What are the main safety concerns with cordyceps and Rhodiola rosea?
- Cordyceps is generally well tolerated in studies, with mostly mild effects. For Rhodiola rosea, watch for mild dizziness, dry mouth or jitteriness; may interact with antidepressants, stimulants, blood-pressure or blood-sugar drugs.
Key studies behind each
Cordyceps
- Chen S, Li Z, Krochmal R, et al. (2010). Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. PubMed 20804368
- Parcell AC, Smith JM, Schulthies SS, et al. (2004). Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance. Int J Sport Nutr Exerc Metab. PubMed 15118196
- Hirsch KR, Smith-Ryan AE, Roelofs EJ, et al. (2017). Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation. J Diet Suppl. PubMed 27408987
- Tuli HS, Sandhu SS, Sharma AK. (2014). Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin. 3 Biotech. PubMed 28324458
Rhodiola Rosea
- Olsson EM, von Schéele B, Panossian AG. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. PubMed 19016404
- Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. (2000). Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. PubMed 11081987
- Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. PubMed 10839209
- Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. (2015). Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial. Phytomedicine. PubMed 25837277
The full evidence reviews
- Cordyceps and performance: a mild aerobic aid, not the energy miracle
Small VO2max and endurance gains show up mainly in older or untrained people; trials in trained athletes come back null, and the cordycepin mechanism is largely preclinical.
Updated August 2026
- Rhodiola rosea: what the evidence actually shows for fatigue, stress, and focus
The adaptogen with the most focused signal — decent short-term RCT data for stress-related fatigue and mental performance under load, a modest mood effect, and systematic reviews that call it promising but not yet proven.
Updated August 2026